Showing 1 – 4 of 4
Relevance | Newest | Oldest |
  • Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2023; 6(9):e2333933. 10.1001/jamanetworkopen.2023.33933

    This nonrandomized clinical trial evaluates patient-reported outcomes in a clinical trial evaluating omission of breast surgery for invasive cancers with exceptional response to neoadjuvant systemic therapy.

  • When Leaning In Becomes Unhealthy, Can We Fix It?

    Abstract Full Text
    JAMA Surg. 2021; 156(10):915-916. 10.1001/jamasurg.2021.3302
  • Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2021; 4(4):e216322. 10.1001/jamanetworkopen.2021.6322

    This cohort study evaluates the continued use of sentinel lymph node biopsy for axillary staging in older patients with early-stage breast cancer and greater likelihood of having more comorbidities and functional limitations.